HIGHLIGHTS
- who: Christos Fokoloros and colleagues from the National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece have published the article: Case Report Systemic Mastocytosis in a Patient with BCR-ABL1-Positive Chronic Myeloid Leukemia in the Remission Phase, in the Journal: Case Reports in Hematology of 25/Oct/2022
- what: The authors report a case of diagnosing SM in a patient in complete molecular remission of CML after stopping TKI treatment.
SUMMARY
Systemic mastocytosis (SM) is a rare myeloid neoplasm. According to current guidelines, SM is classifed into subgroups . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.